// Latest Publications:
200. Association of Podometrics Findings in Patients With Hypertension and Type 2 Diabetes: A Retrospective Analysis. Hypertension 2025 (in press) (IF 7.2)
Paschen C, Koeller MC, Schachner H, Nackenhorst M, Kläger J, Oszwald A, Dörr K, Kammer M, Kozakowski N, Rees A, Kain R, Hecking M, Oberbauer R, Regele H
199. Association of urinary EGF, FABP3, and VCAM1 levels with the progression of early diabetic kidney disease. Kidney Blood Press Res 2024, 49(1):1013-1025 (IF 2.3)
Keller F, Denicolò S, Leierer J, Kruus M, Heinzel A, Kammer M, Ju W, Nair V, Burdet F, Ibberson M, Menon R, Otto E, Choi YJ, Pyle L, Ladd P, Bjornstad PM, Eder S, Rosivall L, Mark PB, Wiecek A, Heerspink HJL, Kretzler M, Oberbauer R, Mayer G, Perco P.
198. Cilgavimab and Tixagevimab as pre-exposure prophylaxis in vaccine non-responder kidney transplant recipients during a period of prevalent SARS-CoV-2 BA.2 and BA.4/5 variants – a prospective cohort study (RESCUE-TX). EBioMedicine 2024, 109:105417 (IF 9.7)
Reindl-Schwaighofer R, Heinzel A, Raab L, Strassl R, Herz CT, Regele F, Doberer K, Helk O, Spechtl P, Aschauer C, Hu K, Jagoditsch R, Reiskopf B, Böhmig GA, Benka B, Mahr B, Stiasny K, Weseslindtner L, Kammer M, Wekerle T, Oberbauer R.